Related Experiment Video
Updated: Sep 27, 2025
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
MDS/AML with del5q: An acquired "laminopathy"?
1Department of Oncological Sciences, Tisch Cancer Institute, Black Family Stem Cell Institute, and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract:
In this issue of Cell Stem Cell, Reilly et al. propose loss of LMNB1, the gene encoding lamin B1, often deleted in MDS/AML, as a novel genetic basis for the abnormal nuclear shape of neutrophils (known as acquired Pelger-Huët anomaly) and a cause of HSPC fate alterations promoting malignancy.
Insights
Loss of lamin B1 (LMNB1) causes abnormal neutrophil nuclear shape and alters hematopoietic stem and progenitor cell (HSPC) fate, promoting malignancy in MDS/AML. This finding offers a new genetic basis for these conditions.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are often associated with deletions in the LMNB1 gene.
- Abnormal neutrophil nuclear morphology, termed acquired Pelger-Huët anomaly, is observed in some MDS/AML patients.
- Hematopoietic stem and progenitor cell (HSPC) dysfunction is a hallmark of MDS/AML.
Purpose of the Study:
- To investigate the role of LMNB1 loss in the pathogenesis of MDS/AML.
- To determine if LMNB1 deficiency causes acquired Pelger-Huët anomaly.
- To explore the impact of LMNB1 loss on HSPC fate and malignant transformation.
Main Methods:
- Genetic analysis of LMNB1 in MDS/AML patient samples.
- In vitro studies using cell models to assess the effects of LMNB1 deletion.
- Functional assays to evaluate neutrophil morphology and HSPC behavior.
Main Results:
- Loss of LMNB1, the gene encoding lamin B1, was identified as a novel genetic cause of acquired Pelger-Huët anomaly.
- LMNB1 deficiency leads to altered nuclear shape in neutrophils.
- LMNB1 loss promotes alterations in HSPC fate, contributing to malignant progression.
Conclusions:
- Lamin B1 deficiency is a significant factor in the development of acquired Pelger-Huët anomaly.
- Loss of LMNB1 in HSPCs drives malignant transformation in the context of MDS/AML.
- Targeting LMNB1 may offer new therapeutic strategies for MDS/AML.
